PL2557920T3 - Kompozycja zawierająca sproszkowaną błonę skorupy jajka przeznaczona do wykorzystania w terapii cukrzycy - Google Patents

Kompozycja zawierająca sproszkowaną błonę skorupy jajka przeznaczona do wykorzystania w terapii cukrzycy

Info

Publication number
PL2557920T3
PL2557920T3 PL11769433T PL11769433T PL2557920T3 PL 2557920 T3 PL2557920 T3 PL 2557920T3 PL 11769433 T PL11769433 T PL 11769433T PL 11769433 T PL11769433 T PL 11769433T PL 2557920 T3 PL2557920 T3 PL 2557920T3
Authority
PL
Poland
Prior art keywords
composition
diabetes mellitus
treating diabetes
eggshell membrane
powdered eggshell
Prior art date
Application number
PL11769433T
Other languages
English (en)
Inventor
Kevin Ruff
Original Assignee
Esm Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esm Holdings Llc filed Critical Esm Holdings Llc
Publication of PL2557920T3 publication Critical patent/PL2557920T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL11769433T 2010-04-12 2011-04-12 Kompozycja zawierająca sproszkowaną błonę skorupy jajka przeznaczona do wykorzystania w terapii cukrzycy PL2557920T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32330310P 2010-04-12 2010-04-12
EP11769433.1A EP2557920B1 (en) 2010-04-12 2011-04-12 Composition comprising powdered eggshell membrane for use in treating diabetes mellitus
PCT/US2011/032103 WO2011130261A1 (en) 2010-04-12 2011-04-12 Methods for treating glucose metabolic disorders

Publications (1)

Publication Number Publication Date
PL2557920T3 true PL2557920T3 (pl) 2015-04-30

Family

ID=44798988

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14182072.0T PL2842563T3 (pl) 2010-04-12 2011-04-12 Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym
PL11769433T PL2557920T3 (pl) 2010-04-12 2011-04-12 Kompozycja zawierająca sproszkowaną błonę skorupy jajka przeznaczona do wykorzystania w terapii cukrzycy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL14182072.0T PL2842563T3 (pl) 2010-04-12 2011-04-12 Kompozycja zawierająca sproszkowaną błonę skorupki jaj do stosowania w leczeniu ssaków w stanie przedcukrzycowym

Country Status (13)

Country Link
US (2) US8679551B2 (pl)
EP (2) EP2842563B1 (pl)
CN (2) CN103002736B (pl)
AU (1) AU2011240764B2 (pl)
CA (1) CA2796336C (pl)
CY (2) CY1116808T1 (pl)
ES (2) ES2579340T3 (pl)
MX (1) MX2012011881A (pl)
NZ (1) NZ602949A (pl)
PL (2) PL2842563T3 (pl)
PT (2) PT2842563T (pl)
RS (2) RS53826B1 (pl)
WO (1) WO2011130261A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2440390B1 (es) * 2012-07-25 2014-11-13 Bioibérica, S.A. Composiciones para el tratamiento del sobrepeso y de la obesidad
JP5998350B2 (ja) * 2013-03-27 2016-09-28 国立大学法人 東京大学 卵殻膜成分を含む肝保護剤ならびにそれを用いた医薬組成物、食品添加物および食品
JP2014231487A (ja) * 2013-05-28 2014-12-11 国立大学法人 東京大学 卵殻膜成分を含むサーチュイン遺伝子活性化剤ならびにそれを用いた組成物
US20140363519A1 (en) * 2013-06-11 2014-12-11 The University Of Tokyo Activator of gene expression of molecular chaperone gene comprising eggshell membrane component and composition thereof
US11478504B2 (en) 2013-07-08 2022-10-25 International Dehydrated Foods, Inc. Compositions and methods for preventing/treating metabolic syndrome
ES3052699T3 (en) * 2013-07-08 2026-01-13 Int Dehydrated Foods Inc Compositions prepared from poultry for use in the treatment of diabetes
JP6056064B2 (ja) * 2013-11-29 2017-01-11 国立大学法人 東京大学 卵殻膜成分を含むインスリン抵抗性改善剤ならびにそれを用いた組成物
CN118272477B (zh) * 2024-04-25 2025-01-10 华中农业大学 用于降血糖的蛋壳膜水解物、肽及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652221A (en) * 1994-11-07 1997-07-29 The University Of Virginia Patent Foundation Method of treating defective glucose metabolism using synthetic insulin substances
GB0213612D0 (en) * 2002-06-13 2002-07-24 Novartis Nutrition Ag Organic compounds
DE20213669U1 (de) * 2002-09-02 2004-02-12 Ewald Speth Antriebstechnik Gmbh Direkt angetriebene Antriebsachse mit einer an axial festgelegtes Sonnenritzel aufweisenden Getriebestufe
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
KR100662903B1 (ko) * 2004-12-14 2007-01-02 건국대학교 산학협력단 글루코사민 하이드로클로라이드를 함유하는 당뇨 질환치료용 의약 조성물
CA2556343A1 (en) * 2005-09-01 2007-03-01 Purepharm Inc. Synthetic nutritional formulations
JP2012518617A (ja) * 2009-02-23 2012-08-16 ディーエスエム アイピー アセッツ ビー．ブイ． 炎症性疾患のためのキマメ（Ｃａｊａｎｕｓ）抽出物およびグルコサミン

Also Published As

Publication number Publication date
WO2011130261A1 (en) 2011-10-20
RS53826B1 (sr) 2015-06-30
US20140193516A1 (en) 2014-07-10
AU2011240764B2 (en) 2014-07-10
ES2528413T3 (es) 2015-02-10
CY1116808T1 (el) 2017-03-15
RS55025B1 (sr) 2016-11-30
CA2796336A1 (en) 2011-10-20
CN105250335A (zh) 2016-01-20
CN105250335B (zh) 2019-10-29
EP2842563B1 (en) 2016-05-25
ES2579340T3 (es) 2016-08-10
US20130089619A1 (en) 2013-04-11
CY1117799T1 (el) 2017-05-17
EP2842563A1 (en) 2015-03-04
PT2842563T (pt) 2016-07-14
PL2842563T3 (pl) 2016-12-30
CN103002736B (zh) 2015-11-25
MX2012011881A (es) 2013-04-19
EP2557920B1 (en) 2014-11-12
NZ602949A (en) 2014-11-28
US8679551B2 (en) 2014-03-25
PT2557920E (pt) 2015-02-05
EP2557920A4 (en) 2013-10-23
CN103002736A (zh) 2013-03-27
US8927032B2 (en) 2015-01-06
CA2796336C (en) 2018-06-05
AU2011240764A1 (en) 2012-11-08
EP2557920A1 (en) 2013-02-20

Similar Documents

Publication Publication Date Title
IL215925A0 (en) Electrokinetically-altered fluid compositions and use thereof for treating insulin resistance and diabetes mellitus
EP2718317A4 (en) GLUCOSE-DEPENDENT INSULINOTROPE POLYPEPTIDE ANALOGUE, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
IL218648A (en) Incretin imitators for use in the treatment of type 2 diabetes
ZA201200224B (en) Long acting insulin composition
PT2557920E (pt) Composição que compreende uma membrana de casca de ovo em pó para utilização no tratamento de diabetes mellitus
EP2564830A4 (en) AQUEOUS COMPOSITION CONTAINED IN A CONTAINER
IL215684A0 (en) Trehalulose-containing composition, its preparation and use
ZA201208413B (en) Skin treatment composition
IL222576A0 (en) Fexofenadine-based composition and preparation process therefor
PL2691109T3 (pl) Zapobieganie hipoglikemii u pacjentów z cukrzycą typu 2
ZA201208409B (en) Hard surface treatment composition
EP2599490A4 (en) COMPOSITION FOR TREATMENT OF INJURY, FORMULATION AND USE THEREOF
ZA201302113B (en) Caspofungin composition
GB201011095D0 (en) Improvements in or relating to ophthalmology
ZA201209701B (en) Improvements in or relating to ophthalmology
EP2570141A4 (en) DERIVATIVE FILLING COMPOSITION
IL216105A0 (en) Non-cating salt composition, preparation process and use thereof
PL2407147T3 (pl) Kompozycja o działaniu bioregeneracyjnym, wzmacniającym i eutrofizującym
GB201015700D0 (en) Improvements in or relating to apparatus for use with sterilant vapour generations
PT2459207E (pt) Composição farmacêutica para tratamento de condições médicas e um método para tratamento de distúrbios alimentares e doenças relacionadas
PL2534302T3 (pl) Kompozycja do obróbki powierzchni
ZA201208568B (en) Skin treatment composition
GB201011094D0 (en) Improvements in or relating to ophthalmology
EP2412357A4 (en) PACKAGING OF MEDICINAL COMPOSITION
EP2455090A4 (en) MEANS TO INHIBIT THE INCREASE OF THE POSTPRANDIAL BLOOD INSULIN MIRROR